By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:



Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.

Company News
Chrono Therapeutics, Inc. Receives Second Fast Track SBIR Grant From National Cancer Institute For Patient-Individualized Smoking Cessation Therapy 8/25/2015 6:29:37 AM
Kerafast Partners With The National Cancer Institute - Enables Sharing Of NCI Research Materials Through Kerafast Platform 8/19/2015 10:21:58 AM
Lightpoint Medical, Ltd Secures Grant From National Cancer Institute 8/6/2015 7:05:02 AM
IriSys, Inc. Awarded Long Term Contract By National Cancer Institute For Manufacturing Clinical Trial Materials 7/15/2015 11:00:54 AM
Elsevier, Inc. And U.S. National Cancer Institute Implement Reciprocal Linking Between Research Articles And Datasets 7/9/2015 9:24:19 AM
National Cancer Institute Awards Huntsman Cancer Institute Elite Comprehensive Cancer Center Designation 7/9/2015 8:16:40 AM
SeraCare Life Sciences, Inc. (SRLS) Signs CRADA With National Cancer Institute To Advance Cancer Diagnostics 6/29/2015 6:36:27 AM
Guardant Health Partners With National Cancer Institute On First Ever Prospective Study To Implement cfDNA Genomic Profiling For Non-Small Cell Lung Cancer 6/24/2015 6:44:43 AM
National Cancer Institute Accepts Rexahn Pharmaceuticals, Inc. (RNN)'s RX-21101 For Its Nanotechnology Characterization Laboratory's Preclinical Characterization Program 6/8/2015 7:50:46 AM
GlobeImmune, Inc. (GBIM) Announces Opening Of Randomized Phase 2 Chordoma Trial At National Cancer Institute 4/22/2015 10:42:17 AM